Elutia Inc. is a forward-thinking commercial-stage biotechnology company headquartered in Silver Spring, Maryland, dedicated to revolutionizing surgical outcomes through its innovative drug-eluting biomatrix technologies. With a strong emphasis on addressing pressing unmet medical needs, Elutia's technologies stand to redefine traditional surgical practices, positioning the company as a key player in the biopharmaceutical sector. As it continues to advance its pipeline and drive breakthroughs in targeted therapies, Elutia showcases significant potential for growth and long-term impact within the healthcare industry.